Clinical outcomes of ischemic stroke patients after thrombolytic therapy

被引:3
作者
do Nascimento, Kleiton Goncalves [1 ]
Ribeiro Chavaglia, Suzel Regina [1 ]
Pires, Patricia da Silva [2 ]
Felix Ribeiro, Sonia Beatriz [1 ]
Barbosa, Maria Helena [1 ]
机构
[1] Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil
[2] Univ Fed Bahia, Vitoria Da Conquista, BA, Brazil
关键词
Stroke; Thrombolytic therapy; Tissue plasminogen activator; TISSUE-PLASMINOGEN ACTIVATOR; SYMPTOMATIC INTRACRANIAL HEMORRHAGE; SAFE IMPLEMENTATION; REGISTRY; MULTICENTER; PREDICTORS; CARE; GUIDELINES; MANAGEMENT; BRAZIL;
D O I
10.1590/1982-0194201600091
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: To analyze outcomes and associated factors in ischemic stroke patients submitted to thrombolytic therapy. Methods: This was a retrospective cohort study of ischemic stroke patients submitted to thrombolytic therapy. Comorbidities, neurologic deficits and time of thrombolysis were described. The chi-squared test was used to assess association among comorbidities, time of thrombolysis, and occurrence of hemorrhagic transformation. Results: There was a high frequency of comorbidities. Mean neurological deficit score was 15 points. Mean time window was 98 minutes and needle-to-door time, 89.9 minutes. Hemorrhagic transformation was observed in 20 patients. Bivariate analysis revealed that hemorrhagic transformation was associated with greater neurologic deficit score, atrial fibrillation and heart disease. Neurologic deficit fell from 51% to 12.5% between admission and discharge. Conclusion: Thrombolytic therapy presented positive outcomes, regardless of long thrombolysis time and high neurologic deficit scores.
引用
收藏
页码:650 / 657
页数:8
相关论文
共 31 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   Predictors of In-hospital Mortality and the Risk of Symptomatic Intracerebral Hemorrhage after Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke [J].
Al-Khaled, Mohamed ;
Matthis, Christine ;
Eggers, Juergen .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (01) :7-11
[3]   Changes in European Label and Guideline Adherence After Updated Recommendations for Stroke Thrombolysis Results From the Safe Implementation of Treatments in Stroke Registry [J].
Anani, Nadim ;
Mazya, Michael V. ;
Bill, Olivier ;
Chen, Rong ;
Koch, Sabine ;
Ahmed, Niaz ;
Wahlgren, Nils ;
Moreira, Tiago Prazeres .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (06) :S155-S162
[4]   Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study [J].
Aoki, Shiro ;
Hosomi, Naohisa ;
Sueda, Yoshimasa ;
Kono, Tomoyuki ;
Takamatsu, Kazuhiro ;
Ohyama, Hideo ;
Torii, Tsuyoshi ;
Kitamura, Takeshi ;
Nomura, Eiichi ;
Noda, Koichi ;
Ohtsuki, Toshiho ;
Matsumoto, Masayasu .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (12) :2747-2753
[5]   Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke [J].
Berkowitz, Aaron L. ;
Mittal, Manoj K. ;
McLane, Hannah C. ;
Shen, Gordon C. ;
Muralidharan, RajaNandini ;
Lyons, Jennifer L. ;
Shinohara, Russell T. ;
Shuaib, Ashfaq ;
Mateen, Farrah J. .
INTERNATIONAL JOURNAL OF STROKE, 2014, 9 (03) :349-355
[6]   Racial and Gender Differences in Stroke Severity, Outcomes, and Treatment in Patients with Acute Ischemic Stroke [J].
Boehme, Amelia K. ;
Siegler, James E. ;
Mullen, Michael T. ;
Albright, Karen C. ;
Lyerly, Michael J. ;
Monlezun, Dominique J. ;
Jones, Erica M. ;
Tanner, Rikki ;
Gonzales, Nicole R. ;
Beasley, T. Mark ;
Grotta, James C. ;
Savitz, Sean I. ;
Martin-Schild, Sheryl .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (04) :E255-E261
[7]   Stroke-Associated Pneumonia in Thrombolyzed Patients: Incidence and Outcome [J].
Bruening, Toralf ;
Al-Khaled, Mohamed .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (08) :1724-1729
[8]   Frequency and predictors of symptomatic intracranial hemorrhage after intravenous thrombolysis for acute ischemic stroke in a Brazilian public hospital [J].
Cougo-Pinto, Pedro Telles ;
dos Santos, Bruno Lopes ;
Dias, Francisco Antunes ;
Cabette Fabio, Soraia Ramos ;
Werneck, Ilana Vaula ;
Camilo, Millene Rodrigues ;
Abud, Daniel Giansante ;
Leite, Joao Pereira ;
Pontes-Neto, Octavio Marques .
CLINICS, 2012, 67 (07) :739-743
[9]   Barriers to the utilization of thrombolysis for acute ischaemic stroke [J].
Eissa, A. ;
Krass, I. ;
Bajorek, B. V. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (04) :399-409
[10]   Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials [J].
Emberson, Jonathan ;
Lees, Kennedy R. ;
Lyden, Patrick ;
Blackwell, Lisa ;
Albers, Gregory ;
Bluhmki, Erich ;
Brott, Thomas ;
Cohen, Geoff ;
Davis, Stephen ;
Donnan, Geoffrey ;
Grotta, James ;
Howard, George ;
Kaste, Markku ;
Koga, Masatoshi ;
von Kummer, Ruediger ;
Lansberg, Maarten ;
Lindley, Richard I. ;
Murray, Gordon ;
Olivot, Jean Marc ;
Parsons, Mark ;
Tilley, Barbara ;
Toni, Danilo ;
Toyoda, Kazunori ;
Wahlgren, Nils ;
Wardlaw, Joanna ;
Whiteley, William ;
del Zoppo, Gregory J. ;
Baigent, Colin ;
Sandercock, Peter ;
Hacke, Werner .
LANCET, 2014, 384 (9958) :1929-1935